Together, the findings indicate that CYP epoxy metabolites are released and accumulated in the circulation of ESRD HD patients, compared to controls, with epoxy metabolite substrate classes unequally hydrolyzed by sEH in vivo. Here, EPHX2 is linked to Huntington disease.